Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Doximity ( (DOCS) ) is now available.
On August 13, 2025, Doximity announced that its General Counsel, Corporate Secretary, and Chief Compliance Officer, Jennifer Chaloemtiarana, will step down from her roles effective August 29, 2025, with John Vaughan taking over these positions. Chaloemtiarana will continue in an advisory role until November 17, 2025, after which she will receive post-employment benefits as per her offer letter.
The most recent analyst rating on (DOCS) stock is a Hold with a $58.00 price target. To see the full list of analyst forecasts on Doximity stock, see the DOCS Stock Forecast page.
Spark’s Take on DOCS Stock
According to Spark, TipRanks’ AI Analyst, DOCS is a Outperform.
Doximity’s overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust growth and strategic advancements in AI. While technical indicators show a positive trend, the high P/E ratio suggests potential overvaluation, slightly tempering the overall score.
To see Spark’s full report on DOCS stock, click here.
More about Doximity
Doximity operates in the healthcare industry, providing a professional network platform for medical professionals, focusing on enhancing communication and collaboration among healthcare providers.
Average Trading Volume: 2,275,035
Technical Sentiment Signal: Buy
Current Market Cap: $11.91B
Learn more about DOCS stock on TipRanks’ Stock Analysis page.